Abdali Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Crohn's disease3 trials
• Heart failure1 trial
• Sickle cell disease1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Active, not recruiting3 trials
• Completed2 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Janssen-Cilag Ltd.1 trial
• Jordan Collaborating Cardiology Group1 trial
• Novo Nordisk A/S1 trial

Running trials

• Active, not recruiting

  A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

  NCT05347095· Phase 3· Janssen-Cilag Ltd.· Source

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT05242471· Phase 2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

  NCT05197049· Phase 3· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  Iron Deficiency in Patients With Heart Failure and Reduced and Mildly Reduced Ejection Fraction

  NCT05992116· Jordan Collaborating Cardiology Group· Source

• Completed

  Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

  NCT05405114· Phase 2· Novo Nordisk A/S· Source